Sexual Wellness Market Size ($81,394.49Mn by 2028) Lead by Capsules Segment (6.6% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
October 29, 2021 09:31 ET
|
The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Sexual Wellness Market: Key InsightsAccording to our new research study on Sexual Wellness Market Size and Forecast to 2028 - COVID-19 Impact and Global...
Global Sexual Wellness Market (2021 to 2026) - Featuring Diamond Products, Reckitt Benckiser and Okamoto Industries Among Others
October 15, 2021 06:23 ET
|
Research and Markets
Dublin, Oct. 15, 2021 (GLOBE NEWSWIRE) -- The "Sexual Wellness Market - Global Outlook & Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The sexual wellness...
Global Contraceptives Market Report 2021: Market to Reach $29.1 Billion by 2027 - Unmet Contraception Needs Signals Huge Market Penetration Opportunities
August 18, 2021 07:48 ET
|
Research and Markets
Dublin, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The "Contraceptives - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Contraceptives Market to...
Insights on the Contraceptives Global Market to 2028 - Increasing Awareness About Sexually Transmitted Diseases Presents Opportunities
July 30, 2021 09:13 ET
|
Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "Contraceptives Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, End User, Distribution Channel" report has been added to...
Worldwide Contraceptive Devices Industry to 2025 - Players Include Allergan Plc, Bayer Healthcare and Cooper Surgical Among Others
February 04, 2021 06:48 ET
|
Research and Markets
Dublin, Feb. 04, 2021 (GLOBE NEWSWIRE) -- The "Contraceptive Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition
March 14, 2018 07:45 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX), a women's healthcare company today announced that an abstract related to the Phase 3 SECURE study for...
Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
March 12, 2018 16:15 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company, today reported financial results for the three months and year ended...
Global Intra-Uterine Contraceptive Device (IUDs), a Safer Way to Birth Control Measure with Reversible Contraception is Expected to Reach USD 5.27 Billion by 2023
January 31, 2018 06:49 ET
|
Energias Market Research
NEW YORK, Jan. 31, 2018 (GLOBE NEWSWIRE) -- The global intra-uterine contraceptive device market is expected to grow steadily from USD 3.80 billion in 2016 to USD 5.27 billion in 2023, at a CAGR of...
Agile Therapeutics to Host First Analyst Day on October 10, 2017
October 02, 2017 07:30 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that the Company will host its first Analyst Day on Tuesday,...
Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock
August 03, 2017 08:23 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women’s healthcare company, today announced the pricing of its underwritten public...